The bluegrass musician's mom Debra died of a drug overdose in June Rachel DeSantis is a senior writer on the music team at PEOPLE. She has been working at PEOPLE since 2019, and her work has ...
Billy Strings is opening up about the unexpected death of his mother, Debra Apostal, which happened in June. Strings — whose legal name is William Lee Apostal — says his mom wasn't sick leading up to ...
Billy Strings revealed that he wants to set his late mother’s poetry to music for a potential new album during an extensive interview about drug use and addiction on the Dopey podcast. Strings’ mother ...
Billy Strings and his drum-tight (but drumless) band brought two sets and 25 songs of pure bluegrass magic to the first of two back-to-back PPG Paints Arena shows on Friday night. I’m already jealous ...
Hamza is a gaming enthusiast and a Writing Specialist from Pakistan. A firm believer in Keyboard/Mouse supremacy, he will play Tekken with WASD if you let him. He has been writing about games since ...
Singer-songwriter Billy Strings says his guitar has been his best friend for as long as he can remember. "I slept with my guitar when I was 4 or 5 years old," he says. "I'd put it right under the ...
"It was such a huge honor for me to add this guitar solo to this insane medley by my favorite death metal band," Strings explained. By Tyler Jenke Michigan bluegrass aficionado Billy Strings has ...
Google DeepMind's drug discovery company, Isomorphic Labs, is set to launch human trials of its AI-designed drugs. The company is aiming to use cutting-edge AI to design medicines faster, cheaper and ...
Google DeepMind's spinoff Isomorphic Labs is set to begin human trials of a drug desinged completely by Artificial Intelligence. Isomorphic Labs, a drug discovery company spun out of Google DeepMind, ...
Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes as tech ...
Alphabet’s drug discovery arm, Isomorphic Labs, is preparing to enter a new chapter in its ambitious efforts to reshape medicine through artificial intelligence, with its first human clinical trials ...
In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed ...